INTRODUCTION
Pathogenic bacteria have evolved elaborate ways to subvert host cell signaling pathways to their own benefit (Galan, 2000) . The facultative intracellular Gram-positive pathogen Listeria monocytogenes has at its disposal two surface molecules of the internalin family that engage the extracellular region of human receptors to relay signals across the membrane into the host cell cytoplasm. Receptor activation induces rearrangements of the actin cytoskeleton and ultimately causes bacterial invasion of normally nonphagocytic cells. The cytoplasm constitutes a protected niche where L. monocytogenes can replicate and spread to cause systemic disease (Hamon et al., 2006) .
The intestinal epithelium forms the first barrier that L. monocytogenes encounters following uptake with contaminated food. Binding of InlA, also called internalin, to E-cadherin exposed at the tip of intestinal villi initiates uptake of bacteria into epithelial cells, enabling them to breach this barrier (Gaillard et al., 1991; Lecuit et al., 2001; Mengaud et al., 1996; Pentecost et al., 2006) . Colonization of deeper tissues requires the related protein InlB that mediates uptake into a number of cell types including hepatocytes and endothelial cells (Braun et al., 1998; Dramsi et al., 1995; Parida et al., 1998) .
InlB is a bacterial surface protein of 630 amino acids. It shares with InlA the organization of the N-terminal internalin domain comprising a Cap, a variable number of leucine-rich repeats (LRRs) and a so-called interrepeat (IR) region Figure 1A) . A poorly characterized B-repeat is followed by three C-terminal GW domains that noncovalently anchor InlB on the surface of Listeria through interaction with lipoteichoic acid (Braun et al., 1997; Jonquieres et al., 1999) . In addition to the bacteria-bound form, a substantial fraction of InlB is released into the medium as a soluble molecule and elicits a cellular response reminiscent of that caused by hepatocyte growth factor/scatter factor (HGF/SF; Braun et al., 1997; Ireton et al., 1999) . This observation contributed to the identification of the receptor tyrosine kinase Met as receptor for InlB (Shen et al., 2000) . Normally, HGF/SF and Met mediate signals critical for cell survival and migration in embryogenesis and tissue regeneration, but deregulation of Met also plays a major role in tumor invasion (Birchmeier et al., 2003) . Two further receptors for InlB have been described, the complement receptor gC1qR (Braun et al., 2000) and heparan sulfate proteoglycans (HSPGs; Jonquieres et al., 2001) . While the exact function of gC1qR is still under debate, it is clear now that HSPGs significantly enhance InlB-induced Met signaling (Banerjee et al., 2004; Jonquieres et al., 2001) .
InlB is structurally well characterized (Marino et al., 1999 (Marino et al., , 2002 Schubert et al., 2001) , and the interaction sites for all three receptors are known. A fragment comprising Cap and LRR (InlB 241 ; Figure 1A ) is sufficient for Met binding (Shen et al., 2000) , and InlB 321 , a fragment further comprising the IR region, is the minimal fragment capable of receptor activation (Banerjee et al., 2004) . The Met-binding site maps to the concave face of the LRR region where several aromatic amino acids essential for interaction with Met are located (Machner et al., 2003) . In addition to their interaction with lipoteichoic acid, the highly basic GW domains bind gC1qR and HSPGs, and binding of these receptors to the C terminus of InlB is competitive (Jonquieres et al., 2001; Marino et al., 2002) .
Less is known about the six domains of the Met ectodomain that comprise some 900 amino acids (Birchmeier et al., 2003) . Met is produced as a 1390 amino acid single-chain precursor that is cleaved by the cellular protease furin between residues 307 and 308 to yield a disulfide-linked two-chain heterodimer ( Figure 1B) . The completely extracellular a chain, together with amino acids 308-514 of the b chain, forms the N-terminal semaphorin (Sema) domain. The b chain further contains a small cysteine-rich (PSI) and four immunoglobulin-like domains (Ig1-Ig4), a transmembrane helix and the cytoplasmic juxtamembrane and tyrosine kinase domains. The Sema domain, a seven-bladed b-propeller, includes the binding site for the HGF/SF b chain ( Figure 1C ) . Two of the five domains within the HGF/SF a chain bind to Sema as well (Holmes et al., 2007) . The Met Ig domains do not bind HGF/SF and have been proposed to act as a stalk presenting the ligand binding Sema domain . The crystal structure of the Sema-PSI fragment in complex with the HGF/SF b chain has been determined , and homology . The InlB-binding site on Met is so far unknown, but it appears to be distinct from that for HGF/ SF as no competition for binding to Met was observed (Shen et al., 2000) .
Here we map the InlB-binding domains of Met and report two crystal structures of a Met-InlB complex. The structures provide a detailed picture of the interaction between the two proteins and, combined with solution studies with full-length InlB, they explain the mechanism by which full-length InlB activates the Met receptor.
RESULTS

At Least One Ig Domain of Met Is Crucial for Binding of InlB 321
To map the InlB-binding site on Met we used four recombinant variants of the Met ectodomain ( Figures 1B   and 1D ) purified from conditioned medium of stably transfected, gylcosylation-deficient CHO Lec cells. In solidphase binding assays, InlB 321 did not show high-affinity binding to Met 567 , a construct comprising only the Sema and PSI domains ( Figure 1E ). In contrast, InlB 321 bound with high-and virtually identical affinity to longer variants of the Met ectodomain (Met 741 , Met 838 , and Met 928 ) that contain two, three, or four immunoglobulin (Ig)-like domains, respectively ( Figure 1F) complexes in the asymmetric unit contained enzymatically deglycosylated Met and diffracted to 2.8 Å . Crystal form II in a different space group contained Met with truncated N-linked carbohydrate side chains produced by the Lec3.2.8.1 mutant of CHO cells (Stanley, 1989) . These crystals diffracted to 4 Å and also contain two complexes in the asymmetric unit. Both crystal forms were solved by molecular replacement. We used crystal form II only to compare the overall domain arrangement with that of the better diffracting and more extensively refined crystal form I discussed below.
In crystal form I, we modeled the first three Met domains: Sema, PSI, and Ig1, all of which are in direct contact with InlB (Figures 2A and 2B ). Ig2 does not contact InlB, and there is no continuous electron density for this domain. It is, therefore, omitted from the final model. Nevertheless, we could place by molecular replacement an Ig2 homology model that is shown in Figures 2A and 2B . InlB interacts with Met via two interfaces. A contact between the concave face of the InlB LRR region and Met Ig1 forms the primary interface ( Figure 2C ), in agreement with the binding data generated with domain deletion constructs of Met ( Figures 1E and 1F ) or point mutants of InlB (Machner et al., 2003) . The secondary, less extensive contact involves the InlB IR region and the Sema domain of Met ( Figure 2C ) and had not been predicted by binding studies.
Like the InlB IR region, the b chain of HGF/SF contacts the Sema domain on the bottom face of the b-propeller . However, the binding sites for the two ligands on the Sema domain are distant and do not overlap ( Figure 2D ). The HGF/SF b chain contacts the Met a chain at blade 2 and 3 of the Sema domain, whereas InlB contacts the Met b chain at blades 4 to 6. This agrees with the observation that full-length InlB and HGF/SF can bind Met simultaneously (Shen et al., 2000) . Apart from the b chain, HGF/SF has additional domains that interact with Met. To test for a potential overlap of other HGF/SF-binding sites on Met with that of InlB, we performed more extensive competition experiments. These revealed a concentration-dependent, partial competition between InlB 321 and full-length HGF/SF, but neither ligand could displace the other completely ( Figure S1 ).
Flexibility in the Met Ectodomain
The structure of InlB 321 within the complex with Met is virtually identical to several structures of free ligand (Marino et al., 1999 (Marino et al., , 2002 Schubert et al., 2001) . In contrast, Met undergoes major rearrangements in order to bind InlB as demonstrated by the fact that the relative orientation of the Met Sema and PSI domain is radically different in the Met 741 -InlB 321 complex and in the complex of Met 567 with the b chain of HGF/SF . Indeed, upon aligning the Sema domains of the two structures, the Cterminal end of the PSI domain is displaced by some 15 Å ( Figure 2D ). The movement can be described as a rigid body rotation of roughly 60 around an axis close to the linker between the two domains ( Figure 3A ). Two closely spaced glycine residues (G517 and G519) provide sufficient flexibility to make this linker an effective hinge region.
As both of our crystal forms contain two complexes per asymmetric unit, there are four crystallographically independent copies of the complex. We have applied tight noncrystallographic symmetry (NCS) restraints throughout refinement, but each domain was treated as a separate NCS group. This allows us to asses the interdomain flexibility within the Met 741 -InlB 321 complex. The two complexes in crystal form I are almost identical. This is not surprising, as the NCS in crystal form I is very close to a crystallographic symmetry and may merely represent the breakdown of this perfect symmetry. The two copies in crystal form II are truly independent of each other and of the complex from crystal form I. Nevertheless, the overall domain arrangement of the complexes from crystal form II is similar to that of crystal form I, and the secondary interface between the InlB IR region and the Met Sema domain is preserved. An overlay of the complexes performed on InlB shows that the Ig1 domain, the PSI domain, and the InlB-proximal side of the Sema domain overlap very well and that large movements are limited to Ig2 and the InlB-distal side of the Sema domain due to a crystal lattice contact ( Figure 3B ).
Details of the Primary Interface between the InlB LRR Region and Met Ig1
Met 741 is the largest fragment of the Met ectodomain crystallized to date, and the structure of the Met Ig1 domain has not been reported before, except for a homology model . Ig1 is an immunoglobulinlike domain with a disulfide bridge linking strands D and E. An unusually long B-C loop forms a unique b-hairpin extending from the core ( Figure 4A ). The hairpin, which we term b-wing, is a key element for InlB binding. The bwing lies at the center of the primary interface between the concave face of the InlB LRR and Met Ig1 in which some 1700 Å 2 of surface area are buried. The LRR-Ig1 contact is reminiscent of InlA that likewise binds the Ig-like domain EC1 of human E-cadherin in the void of its larger, horseshoe-shaped LRR (Schubert et al., 2002) . However, unlike EC1, which is located centrally within the LRR of InlA, the core of Met Ig1 is offset by some 16 Å toward the loops connecting the 3 10 -helices and b strands of the InlB LRR ( Figure 4A ). Only the b-wing and the top of the Ig fold are in direct contact with the ligand. Two potential glycosylation sites are located at the bottom of Ig1, implying that the carbohydrate side chains present in native Met should neither interfere with nor participate in ligand binding.
Overall, the LRR-Ig1 interface has a mixed hydrophobic and polar character. A string of aromatic amino acid side Figure 4D ). The PSI domain of Met contributes to the primary contact a single hydrogen bond to the LRR of InlB.
The Secondary Interface between the InlB IR and Met Sema Domain Is Critical for Receptor Activation The second, less prominent contact between InlB IR and Met Sema buries some 870 Å 2 and is mainly polar. The overall strength of the interaction between the IR and Sema domains is low, as we did not observe binding of InlB 321 to Met 567 , which can form the secondary, but not the primary, contact ( Figure 1E) . Moreover, the secondary interface does not measurably contribute to the binding affinity of InlB 321 to Met, as the shorter InlB 241 ( Figure 1A ) that is only capable of binding Ig1 has an apparent affinity for Met similar to InlB 321 ( Figure 5A ). This underscores that LRR-Ig1 is the primary, affinity-determining contact. However, InlB 241 and InlB 321 show clear differences in terms of Met activation. InlB 241 cannot induce Met phosphorylation or Met-dependent activation of Erk1/2 (Banerjee et al., 2004; Figure . 5B), whereas InlB 321 is active in these assays, highlighting the fact that the interaction between the IR and Sema domains is essential for the ability of InlB to activate Met.
Full-Length InlB Induces Receptor Clustering in the Presence of Heparin
Full-length InlB (InlB fl ) is much more active than InlB 321 in receptor phosphorylation assays and, like HGF/SF, it elicits full cell responses such as cell migration (Banerjee et al., 2004; Shen et al., 2000) or DNA synthesis in target cells, which InlB 321 cannot induce ( Figures 5C and 5D ). Receptor dimerization, or more generally oligomerization, is important in the activation of most receptor tyrosine kinases (Hubbard and Till, 2000; Schlessinger, 2000) .
Therefore, we analyzed the oligomerization properties of InlB 321 and InlB fl and their complexes with Met 928 , a soluble form of the Met receptor encompassing the whole ectodomain ( Figure 1B) in the absence or presence of a heparin 12-mer, in view of reports demonstrating that the GW domains of InlB bind heparin and HSPGs (Banerjee et al., 2004; Jonquieres et al., 2001 ). We used analytical ultracentrifugation (AUC), as complexes of InlB fl with its receptor(s) are hardly tractable by size exclusion chromatography due to strong interactions of InlB fl with the matrix at physiological salt concentrations.
InlB 321 is monomeric ( Figure 6A ) and equimolar mixtures of InlB 321 and Met 928 produced a 1:1 complex and a very small faster boundary ( Figure 6C ) that is also visible on sedimentation of Met alone ( Figure S2 ). Addition of heparin did not change the sedimentation behavior of InlB 321 alone ( Figure 6B ) or in complex with Met 928 ( Figure 6D ). Hence, under none of the conditions tested did we observe dimerization of Met upon binding of InlB 321 .
InlB fl alone sediments as a monomer (Banerjee et al., 2004 ; Figure 6E ). Addition of heparin caused extensive aggregation and pelleting of the protein with just 20% of the original material remaining in solution as a 1:1 InlB flheparin complex ( Figure 6F ). InlB fl and Met 928 at 1:1 molar ratio gave a broad peak containing the 1:1 and 2:2 complexes as well as smaller amounts of higher molecular weight species ( Figure 6G ). Addition of heparin had a striking effect. The low molecular weight species disappeared, and most of the material shifted to large sedimentation coefficients ( Figure 6H ). Thus, heparin induced massive clustering of the Met-InlB fl complexes, in striking contrast with the results obtained with mixtures of HGF/SF and Met 928 .
DISCUSSION
InlB 321 Acts as a ''Molecular Clamp'' to Lock Met in a Signaling-Competent Conformation
Electron microscopy has shown that in the absence of ligand, the Met ectodomain is highly flexible (Gherardi et al., 2006) . The large relative rearrangement of the Sema and the PSI domain between the Met-InlB complex and the complex of Met and the HGF/SF b chain confirms these findings. In the latter complex, the Met PSI domain is not constrained by interactions with the ligand. Therefore, the orientation of the PSI domain does not represent a specific HGF/SF-bound conformation. Rather, it will represent one of potentially many conformations that can be sampled by the free Met ectodomain.
In contrast, in the Met-InlB complex the position of the PSI domain is restricted through extensive contacts of its two flanking domains, Sema and Ig1, with the ligand InlB. InlB 321 itself is a rigid unit that hardly changes upon binding to Met. It thus presents a preformed binding site to which the receptor accommodates. We suggest that InlB acts as a ''molecular clamp'' that forces the otherwise flexible receptor into a rigid, signaling-competent conformation. This interpretation provides an explanation for the fact that InlB 321 but not the shorter InlB 241 can induce Met and Erk phosphorylation. Both proteins can bind the Ig1 domain of the receptor, but the lack of the IR domain abrogates the ability of InlB 241 to clamp Met into a signaling-competent conformation via the second interface. Currently we cannot draw definite conclusions about how the intracellular signaling is initiated upon binding of InlB 321 to the extracellular part of Met. However, it is plausible that the rigidification of the Met ectodomain allows receptor molecules in the membrane to pack more closely, which in turn may facilitate crossphosphorylation of the cytoplasmic tyrosine kinase domains.
Full-Length InlB Activates Met by Receptor Clustering
There is evidence that receptor dimerization/oligomerization is a key event in Met activation (Banerjee et al., 2004; Kong-Beltran et al., 2004; Prat et al., 1998) . However, we did not observe dimerization of the Met ectodomain upon binding of InlB 321 in solution. Furthermore, although both crystal form I and II contain two Met 741 -InlB 321 complexes in the asymmetric unit, these dimeric assemblies appear to be caused by crystal packing because the arrangement differs markedly between the two crystal forms and the contacts supporting them bear little specificity, arguing against a potential physiological significance. Finally, we found that mutant forms of InlB in which we disrupted the major contact stabilizing the more plausible dimeric assembly from crystal form I by insertion of an extra LRR retained the ability to activate the Met receptor (data not shown). Hence, how does InlB activate the Met receptor?
Full receptor activation requires the C-terminal GW domains of the full-length protein in addition to the Metbinding N-terminal domain. The present structure, the biological activities of InlB 321 and InlB fl , and the solution behavior of these proteins in complex with Met 928 provide a framework for Met activation by InlB in which receptor clustering plays the pivotal role. InlB exists in two forms, noncovalently associated with the bacterial surface and free in solution (Braun et al., 1997) . It is currently unknown which of these forms normally mediates bacterial invasion, as both induce Met signaling (Bierne and Cossart, 2002) . We have superimposed the structures of the Met 741 -InlB 321 complex and full-length InlB (Marino et al., 2002;  Figure 7A ). This structure-based model seems sterically plausible, as the proteins' C termini associated with the respective cell-surfaces point into almost opposite directions, and suggests that several InlB molecules could activate Met by receptor clustering while being attached to Listeria via interaction between the GW domains and lipoteichoic acid (Jonquieres et al., 1999) . Soluble InlB fl could activate Met by receptor clustering as well, brought about by interaction of the GW domains with HSPGs on the host cell surface ( Figure 7B) .
Two processes contribute to InlB-mediated Met activation, namely clamping of the receptor ectodomain and receptor clustering. Using engineered variants of InlB, these processes can be experimentally separated. Clamping on its own is sufficient for partial activation of Met as evident from receptor phosphorylation studies using InlB 321 , which can clamp but not cluster Met (Shen et al., 2000;  Figure 5C ). Likewise, clustering of Met alone can promote receptor activation in the absence of clamping. This is apparent from experiments in which InlB constructs consisting of only Cap and LRR are artificially clustered. For example, immobilization of Cap-LRR constructs on latex beads allows for efficient Met-mediated entry of beads into cells that do not take up control beads . Fusion of GW domains 2 and 3 to a Cap-LRR fragment also yields a protein that can induce Met phosphorylation, although one requiring approximately 20-fold higher concentrations compared with a version that additionally harbors the IR region (Banerjee et al., 2004) . This strongly suggests that in the physiological context of the full-length protein both processes cooperate to turn InlB into such a potent Met agonist. In summary, activation of the Met receptor by InlB occurs in three steps: (1) a first, high-affinity binding event involving the LRR and Met Ig1, (2) receptor rigidification via the secondary contact involving the IR and the Met sema domain and finally, (3) receptor oligomerisation via the GW domains, a process greatly enhanced by heparin and, presumably, by heparan sulfate on the surface of target cells.
The Binding Site for the HGF/SF a Chain Overlaps with the Secondary Interface for InlB
The structural aspects of the interaction between Met and its natural ligand HGF/SF are still far from being completely understood, certainly owing, at least in part, to problems in the amount and homogeneity of the sample available. Proteins derived from bacteria are generally easier to produce and handle than those of eukaryotic or even mammalian origin. Bacterial virulence factors that interact with eukaryotic host proteins, therefore, often can be turned into useful tools to study not only the process of infection but also the signaling pathway of the host that is targeted. Our structural data in combination with the data from competitive binding studies allow us to draw conclusions pertinent to the interaction of the natural ligand HGF/SF with the Met receptor.
The active form of HGF/SF is a two-chain protein produced by proteolytic cleavage of an inactive, single-chain precursor ( Figure 1C ). The C-terminal b chain forms a single domain homologous to serine proteases (SPH domain). The N-terminal a chain contains five additional domains (an N-terminal [N] and four kringle [K1-K4] domains; Birchmeier et al., 2003) . Out of these six domains, three (N, K1, and SPH) are responsible for HGF/SF binding to the Sema domain of Met (Holmes et al., 2007; Stamos et al., 2004) . No competition for binding to Met would be expected between InlB 321 and the SPH domain of HGF/SF, as the binding sites are distant. The fact that we actually did observe partial competition between InlB 321 and HGF/SF suggests that the N-and/or K1-binding sites overlap, at least partially, with that for InlB IR on the bottom and side faces around blade five of the b-propeller.
Promiscuity of the Met Receptor: InlB Is Not a Molecular Mimic of HGF/SF
The results presented here highlight two important differences in the mechanism of Met binding and activation by InlB and the physiological ligand HGF/SF: (1) In the case of HGF/SF, both the N-terminal (NK1) and the C-terminal moiety (the SPH domain) display Met binding, and both ends of the molecule bind the Sema domain (Holmes et al., 2007; Stamos et al., 2004) . Binding of InlB to Met, in contrast, involves the N-terminal Cap-LRR-IR fragment only (Banerjee et al., 2004; Shen et al., 2000) and crucially depends on the Ig1 domain of Met; (2) Heparin has a massive effect on the oligomerisation of the InlB fl -Met 928 complex ( Figure 6H ) but not on the HGF/SF-Met 928 complex .
The ability of intracellular pathogenic bacteria to exploit receptors on the host cell membrane for cell invasion involves, in a number of instances, bacterial proteins which are structural mimics of the physiological ligand (Stebbins and Galan, 2001) . The intracellular responses elicited by InlB and HGF/SF are similar (Bierne and Cossart, 2002; Shen et al., 2000) , and HGF/SF can even substitute for InlB in inducing bacterial uptake (Banerjee et al., 2004) . However, our work clearly shows that InlB is not a structural mimic of HGF/SF, that the two ligands bind to different regions of the receptor, and that they employ different molecular mechanisms for receptor activation. L. monocytogenes thus relies on a robust, less-regulated approach to achieve maximum receptor activation allowing for efficient bacterial uptake during invasion. Finally, our results demonstrate a striking promiscuity of Met toward different ligands. Over evolutionary periods of time L. monocytogenes has adapted to bind and activate Met by a novel mechanism that may lead us an alternative way to therapeutic approaches against cancer or infection that take into account the Met stalk rather than focusing merely on the Sema domain.
EXPERIMENTAL PROCEDURES
Protein Purification for Crystallization Human Met constructs were produced as secreted, C-terminally His-tagged protein in CHO Lec8 (Met 928 and Met 838 ) or in CHO Lec3.2.8.1 cells (Met 741 and Met 567 ). Cells were grown in SMIF6 medium with 0.5% (Met 838 ) or without FCS (Met 928 and Met 567 ) or in serum-free ProCHO5 medium (Met 741 ). The yield was about 1 to 2 mg of purified protein from 1 liter of culture. So far, we have not been able to produce Met 656 , the variant with only one Ig domain. During the production phase, cells were cultured at 32 C.
Conditioned medium was concentrated and exchanged against 25 mM Na-phosphate pH 7.4, 150 mM NaCl using crossflow and a cartridge with 30 kDa cutoff. The protein was purified by affinity chromatography over NiNTA superflow (Qiagen) followed by MonoS (GE Healthcare) using a NaCl gradient (0.1 M to 1 M) in 50 mM Mes, pH 6.0. The protein was deglycosylated overnight at 20 C using 5 mU of EndoH (Calbiochem) per mg of protein in Na-acetate pH 5.5. Deglycosylated protein was repurified over MonoS as above but using a shallow salt gradient. InlB 321 was expressed as GST-fusion protein from the pETM30 vector in E. coli BL21-CodonPlus(DE3) cells and purified with a yield of about 20 mg per liter essentially as described (Schubert et al., 2001 ) except that TEV protease was used for tag removal. The complex was formed by mixing Met 741 with a molar excess of InlB 321 and was purified using a Superdex200 HR 10/30 column (GE Healthcare) equilibrated in 10 mM Tris, pH 8.0, 50 mM NaCl. The complex was concentrated to 5 mg/ml, and aliquots were frozen at À70 C.
Crystallization and Data Collection
Initial crystals of the deglycosylated protein were grown from the precipitant synergy screen (Majeed et al., 2003) . Diffraction-quality crystals were obtained at 20 C in 96-well sitting-drop plates with 2 ml protein (5 mg/ml) + 1 ml reservoir. The reservoir (70 ml of 16.5% PEG 1500, 4.4% MPD, 0.1 M Tris, pH 8.5) was covered with 20 ml of Al's oil to slow down vapor diffusion. Crystals grew over several weeks to a final size of about 100 3 100 3 50 mm. Crystals typically grew as clusters and had to be broken apart for data collection. Crystals were harvested in mother liquor supplemented with 15% glycerol and were flash frozen in liquid nitrogen. Data were collected at ESRF beamline ID23-2 in three wedges of 70-80 degrees from a single crystal with 1 s exposure and 1 rotation per image. The crystal was translated between wedges because of radiation damage. All data were indexed, integrated, and scaled with the XDS package (Kabsch, 1993) . Data statistics are given in Table S1 .
Structure Determination and Refinement
Crystal form I was solved by molecular replacement in Phaser (McCoy et al., 2005) . Crystal structures or homology models of individual domains of the complex were used as search models: InlB 321 (PDB ID 1h6t; Schubert et al., 2001 ); Sema and PSI domain separately (1shy; Stamos et al., 2004) ; homology models of Ig1 (1ux3) and Ig2 (2cew; Gherardi et al., 2003) . All domains could be located with confidence. A map calculated directly from the solution identified by Phaser was used for correcting Sema, PSI, and InlB and for rebuilding the homology model of Ig1 in coot (Emsley and Cowtan, 2004) . The model was completed by iterative building and refinement. The electron density for domain Ig2 was not continuous and did not allow rebuilding of the homology model. Hence, Ig2 is not included in the final model. The C2 cell contains two complexes in the asymmetric unit with translational NCS one-half along a and c leading to pseudocentering with a noncrystallographic 2-fold parallel to the crystallographic 2-fold axis. Tight NCS restraints on the individual domains were employed throughout refinement in CNS (Brunger et al., 1998) and Refmac5 (Murshudov et al., 1997) . After each cycle of rebuilding, simulated annealing and individual B-factor refinement was carried out in CNS followed by TLS and restrained refinement in Refmac5.
Final steps of refinement were carried out in Phenix (Adams et al., 2004 ) using simulated annealing and tight NCS. B-factors were modeled solely via TLS refinement with 12 TLS groups, one for InlB 321 and one for each Met domain. We did not refine B-factors individually, as this caused only a marginal drop in R free along with a significant drop in R work . The same free-R set was kept in all programs. Refinement statistics are given in Table S2 . Interface analysis and calculation of buried surface areas were carried out using the PISA server (Krissinel and Henrick, 2005) . The electrostatic potential was calculated using APBS (Baker et al., 2001) . Domain motions were analyzed with Dyndom (Hayward and Berendsen, 1998) . Figures were prepared with PyMol (DeLano, 2002) .
Purification of Full-Length InlB
Mature InlB (residues 36-630) was expressed from the vector pETM30 in E. coli BL21-CodonPlus(DE3) cells at 37 C for 4 hr and was purified by affinity chromatography using glutathione-sepharose. InlB was cleaved from the tag with TEV in 50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM DTT. The protein was then purified over MonoQ. To remove remaining nucleic acids, the protein was further purified over MonoS in 50 mM Hepes, pH 7.9, 0.2 M NaCl, 1 mM DTT with a linear salt gradient. The yield was about 0.5 mg of purified protein per liter. Monodispersity of the protein was verified by dynamic light scattering.
Analytical Ultracentrifugation
Sedimentation velocity analysis was performed using a Beckman An60Ti rotor in a ProteomeLab XL-A ultracentrifuge. All runs were at 20 C at speeds of 30,000, 45,000, 50,000, and 60,000 rev.min À1 (as appropriate to the sample) and scanning at 280 nm at the shortest possible time intervals ($1.5 min). Protein samples were in 0.05 M Tris-Cl, 0.1 M NaCl, pH 8.0 (InlB fl and Met 928 ) or in 0.02 M Tris-Cl, 0.1 M NaCl, pH 8.0 (InlB 321 -Met 928 and InlB fl -Met 928 complexes) and were studied at the concentrations given in the legend to Figure 6 . Data were analyzed with DC/DT+ v.2.0.7 (Philo, 2006) to give sedimentation coefficients and, in simple cases, M r , using partial specific volumes and solvent parameters calculated (Laue et al., 1992) with SEDNTERP (Hayes et al., 2006) . Due to the complexity of the mixtures of aggregates in many cases, results are shown as plots of dc/dt against s 20,w since these are directly derived from the data with no assumption about boundary shape.
Met Activation
Phosphorylation of Erk1/2 was studied in Vero (African green monkey kidney) cells using established procedures (Holmes et al., 2007; Rubin et al., 2001 ) except that lysis buffer contained phosphatase inhibitor cocktail 2 (Sigma P5726). Activated and total Erk1/2 were detected with mouse monoclonal (Sigma M8159) or rabbit polyclonal (Promega V114A) antibodies followed by HRP-conjugated secondary antibodies and HRP substrate. Scattering of MDCK colonies (Stoker et al., 1987) in response to truncated or full-length InlB or HGF/SF was assessed by phase contrast micrography 18-24 hr after addition of test proteins using a Leitz IRB55 microscope equipped with a Hamamatsu C5810 3CCD digital camera. DNA synthesis assays were carried out on the MK keratinocyte cell line (Holmes et al., 2007) .
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